Agios' mitapivat met its primary endpoint in a Phase 3 trial for PK deficiency in children. The company plans a marketing ...

The Hemoglobin A1c Testing Devices Market is experiencing significant growth due to rising diabetes prevalence, advancements ...

Measuring fecal hemoglobin concentrations could optimize screening intervals for colorectal cancer and conserve resources, an ...

Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

"Additionally, men experienced a 17% reduced risk of airway obstruction. In women, while higher hemoglobin levels were linked ...

News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.

The following is a summary of “Prevalence, clinical features, and long-term outcome of patients with primary Sjögren’s ...

Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

Positive HIV status as well as socioeconomic disadvantages, not breastfeeding, are associated with infant length and birth ...

ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...